Cargando…

Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis

BACKGROUND: The role of bisphosphonates (BP) in early breast cancer (BC) has been considered controversial. We performed a meta-analysis of all randomized controlled trials (RCTs) that appraised the effects of BP on survival in early BC. METHODS: RCTs were identified by searching the Cochrane Librar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben-Aharon, Irit, Vidal, Liat, Rizel, Shulamith, Yerushalmi, Rinat, Shpilberg, Ofer, Sulkes, Aaron, Stemmer, Salomon M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753308/ https://www.ncbi.nlm.nih.gov/pubmed/23990894 http://dx.doi.org/10.1371/journal.pone.0070044

Ejemplares similares

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014)

Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
por: Kundel, Yulia, et al.
Publicado: (2013)

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Correction: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
por: Ben-Aharon, Irit, et al.
Publicado: (2018)

Doxorubicin-induced ovarian toxicity
por: Ben-Aharon, Irit, et al.
Publicado: (2010)

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016)

The association between smoking and breast cancer characteristics and outcome
por: Goldvaser, Hadar, et al.
Publicado: (2017)

Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Bonilla, Luisa, et al.
Publicado: (2010)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
por: Levi, Mattan, et al.
Publicado: (2020)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
por: Granot, Tal, et al.
Publicado: (2016)

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
por: Landman, Yosef, et al.
Publicado: (2019)

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study
por: Margel, David, et al.
Publicado: (2014)

Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity
por: Goldvaser, Hadar, et al.
Publicado: (2017)

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients
por: Stemmer, Salomon M., et al.
Publicado: (2013)

Treosulfan induces distinctive gonadal toxicity compared with busulfan
por: Levi, Mattan, et al.
Publicado: (2018)

In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels
por: Bar-Joseph, Hadas, et al.
Publicado: (2011)

BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivo
por: Uziel, Orit, et al.
Publicado: (2015)

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines
por: Ninio-Many, Lihi, et al.
Publicado: (2020)

Maintenance Treatment for Patients With Mantle Cell Lymphoma: A Systematic Review and Meta-analysis of Randomized Trials
por: Vidal, Liat, et al.
Publicado: (2018)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry
por: Shachar, Shlomit S., et al.
Publicado: (2023)

The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
por: Fick, Eva-Maria, et al.
Publicado: (2015)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity
por: Ben Aharon, Irit, et al.
Publicado: (2013)

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
por: Stemmer, Salomon M., et al.
Publicado: (2017)

Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis
por: Goldvaser, Hadar, et al.
Publicado: (2019)

Psychological tendencies of children with juvenile idiopathic arthritis
por: Badarnee, Muhammad, et al.
Publicado: (2022)

MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells
por: Ninio-Many, Lihi, et al.
Publicado: (2014)

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy
por: Stemmer, Salomon M., et al.
Publicado: (2019)

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results
por: Diel, I J, et al.
Publicado: (2000)

Should all adjuvant breast cancer patients receive a bisphosphonate?
por: Cameron, David A
Publicado: (2003)

COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
por: Yerushalmi, Rinat, et al.
Publicado: (2021)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Effect of adjuvant bisphosphonates on disease-free survival in early breast cancer: Retrospective analysis results in an unselected single-center cohort
por: Hadji, Peyman, et al.
Publicado: (2013)

NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest
por: Hershkovitz Rokah, Oshrat, et al.
Publicado: (2010)

Breast Cancer during Pregnancy—Current Paradigms, Paths to Explore
por: Alfasi, Ayelet, et al.
Publicado: (2019)

Evolving treatment paradigms in esophageal cancer
por: Turgeman, Ilit, et al.
Publicado: (2021)

Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
por: Stemmer, Amos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_daio5frkka2sp4usmgt1oq0a5m